Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0014118 (
endocarditis
)
15,629
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Candidal endocarditis
can develop if candidemia occurs during Swan-Ganz catheterization. Candida
endocarditis
may persist for many months and is fatal unless the infected valve is resected. Herein is reported the first case of rupture of a mycotic pulmonary artery aneurysm caused by chronic candidal
endocarditis
. The
endocarditis
followed Swan-Ganz catheterization and aneurysm progressed despite appropriate medical and surgical therapy.
...
PMID:Rupture of a pulmonary artery mycotic aneurysm associated with candidal endocarditis. 333 18
Candidal endocarditis
is an uncommon and serious complication of invasive Candida infection in neonates. The aim of this study was to further characterise candidal
endocarditis
in neonates. Between 1995 and 2000, 56 patients were diagnosed with Candida bloodstream infections (CBSI) in the Neonatal Intensive Care Unit of Schneider Children's Medical Center of Israel. Five of them (9%) developed mycetoma of the right atrium. None of the patients had congenital heart disease or a central venous catheter in the right heart at the time of diagnosis. All were treated with amphotericin B alone or in combination with other antifungals, without surgical intervention. One patient died of the disease and one died later of polymicrobial sepsis and necrotizing enterocolitis. A review of the literature since 1980 yielded an additional 25 cases of candidal
endocarditis
. For the whole sample (n = 30) survival rate was 73.1%. Six of the 10 patients treated with antifungal agents and surgery survived (60%), compared with 13 of the 20 patients treated only medically (65%) (P = 1.0). Candida
endocarditis
in neonates differs from fungal
endocarditis
in adults in risk factors, clinical presentation and outcome. As the outcome of surgical and medical treatment are comparable, antifungal therapy alone may be a valid therapeutic option in high-risk cases.
...
PMID:Candida endocarditis in neonates: report of five cases and review of the literature. 1636 18
The incidence of fungal
endocarditis
is increasing. While the pathogenic mechanisms are not fully understood, infection is associated with underlying heart disease and is most often attributable to Candida species.
Candidal endocarditis
complications include heart damage, inflammation, and emboli with resulting ischemia and tissue death.
Candidal endocarditis
is difficult to diagnose as blood cultures are often negative. Treatment includes surgical intervention and antifungal therapy. This case study describes a 41-year-old female complaining of acute onset of pain with numbness and tingling in both lower extremities. Prior history was significant for mycotic valve aneurysm and replacement secondary to culture-negative
endocarditis
. Evidence of limb-threatening ischemia led to a bilateral thrombectomy. During the thrombectomy white debris, later identified as Candida albicans, was encountered. A transesophogeal echocardiogram revealed a pedunculated mass which was determined to be the source of infection. The patient was placed on micafungin and voriconazole and discharged with a diagnosis of C. albicans fungal infection with descending aorta fungal mass. This case study illustrates an unusual presentation of candidal
endocarditis
with discussion of disease epidemiology, pathogenesis, diagnosis, and treatment.
...
PMID:Candidal endocarditis presenting with bilateral lower limb ischemia. 2295 12